Use of Antithrombotic Medications Among Elderly Ischemic Stroke Patients
Judith H. Lichtman, Lisa Naert, Norrina B. Allen, Emi Watanabe, Sara B. Jones, Lisa C. Barry, Dawn M. Bravata, Larry B. Goldstein
Circulation: Cardiovascular Quality and Outcomes. 2010;CIRCOUTCOMES.109.850883Originally published November 23, 2010
Judith H. Lichtman
Norrina B. Allen
Sara B. Jones
Lisa C. Barry
Dawn M. Bravata
Larry B. Goldstein
- Received December 23, 2009
- Accepted October 31, 2010
- Originally published November 23, 2010.
Copyright & Usage:
© 2010 American Heart Association, Inc.
- Judith H. Lichtman, PhD, MPH,
- Lisa Naert, BS,
- Norrina B. Allen, PhD,
- Emi Watanabe, MPH,
- Sara B. Jones, MPH,
- Lisa C. Barry, PhD, MPH,
- Dawn M. Bravata, MD and
- Larry B. Goldstein, MD
- From the Section of Chronic Disease Epidemiology (J.H.L., E.W., S.B.J.), Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn; the Iowa Foundation for Medical Care (L.N.), West Des Moines, Iowa; the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill; the Department of Internal Medicine (L.C.B.), Yale School of Medicine, New Haven, Conn; VA Health Services Research and Development Center of Excellence on Implementing Evidence-Based Practice and the Health Services Research and Development Stroke Quality Enhancement Research Initiative (D.M.B.); Richard L. Roudebush VA Medical Center (D.M.B.); the Department of Internal Medicine (D.M.B.), Indiana University School of Medicine, and Regenstrief Institute, Indianapolis, Ind; and the Department of Medicine (Neurology) (L.B.G.), Duke Stroke Center, Center for Clinical Health Policy Research, Duke University and Durham VAMC, Durham, NC.
- Correspondence to Judith H. Lichtman, PhD, Yale University School of Medicine, PO Box 208034, New Haven, CT 06520.8034. E-mail